Ysios Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
11
- Investments
-
72
- Portfolio
-
26
- Exits
-
17
Ysios Capital General Information
Company Description
Founded in 2008, Ysios Capital is a venture capital firm based in San Sebastián, Spain. The firm seeks to invest in biotech ventures developing novel drugs, across a diversity of modalities and therapeutic areas.
Business Details
Website
www.ysioscapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Avenida de la Libertad
- 25, 4th floor
- 20004 San Sebastian
- Spain
Ysios Capital Investments (72)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| SpliceBio | 11-Jun-2025 | Later Stage VC | Biotechnology | Generating Revenue | ||
| ReproNovo | 20-May-2025 | Other Healthcare Services | Clinical Trials - Phase 2 | |||
| Neurona Therapeutics | 28-Mar-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Anaconda Biomed | 09-Jan-2025 | Therapeutic Devices | Generating Revenue | |||
| Adcendo | 06-Nov-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Memo Therapeutics | 07-May-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Engrail Therapeutics | 14-Mar-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Neurona Therapeutics | 06-Feb-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Kynexis | 07-Nov-2023 | Early Stage VC | Drug Discovery | Startup | ||
| Tagworks | 01-Jun-2023 | Later Stage VC | Drug Delivery | Pre-Clinical Trials |
Ysios Capital Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Mineralys | 09-Feb-2023 | IPO | |
| Sanifit | 22-Nov-2021 | ||
| Aura Biosciences | 02-Nov-2021 | ||
| Barostim | 30-Jun-2021 | ||
| Lava Therapeutics | 25-Mar-2021 | ||
| Rainier Therapeutics | 04-Mar-2021 | ||
| Galecto | 29-Oct-2020 | ||
| DermaLumics | 01-Sep-2018 | ||
| STAT-Dx | 19-Apr-2018 | Merger/Acquisition | |
| Prexton Therapeutics | 16-Mar-2018 | Merger/Acquisition |
Ysios Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Ysios Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Ysios Capital Co-Investors (110)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Forbion | 3 |
|
|
||
| Gilde Healthcare |
|
|
|||
| Lundbeckfonden BioCapital |
|
|
|||
| Schroders Capital |
|
|
|||
| BioGeneration Ventures |
|
|
Ysios Capital FAQs
-
What is Ysios Capital?
Founded in 2008, Ysios Capital is a venture capital firm based in San Sebastián, Spain.
-
When was Ysios Capital founded?
Ysios Capital was founded in 2008.
-
Where is Ysios Capital headquartered?
Ysios Capital is headquartered in San Sebastian, Spain.
-
What is Ysios Capital's total asset value?
Ysios Capital has around in total assets under management.
-
How many investments has Ysios Capital made?
Ysios Capital has made 72 investments.
-
What has Ysios Capital invested in?
Ysios Capital has made numerous investments in companies like SpliceBio, ReproNovo, and Neurona Therapeutics within the Biotechnology, Healthcare Services, and Drug Discovery industries.
-
What has Ysios Capital invested in recently?
Ysios Capital's latest investment was on 11-Jun-2025 in SpliceBio, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
